Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Giovanni Maga

Showing results (181-190 of 214) with videos related to

Pageof 22
Sort By:
Journal of Medicinal Chemistry|March 3, 2006
Pyrazolo[3,4-d]pyrimidines as potent antiproliferative and proapoptotic agents toward A431 and 8701-BC cells in culture via inhibition of c-Src phosphorylationFabio Carraro, Antonella Naldini, Annalisa Pucci, et al.
Journal of Medicinal Chemistry|December 13, 2005
Parallel solution-phase and microwave-assisted synthesis of new S-DABO derivatives endowed with subnanomolar anti-HIV-1 activityFabrizio Manetti, José A Esté, Imma Clotet-Codina, et al.
European Journal of Medicinal Chemistry|September 10, 2025
Developing Type II F508del-CFTR correctors with a protective effect against respiratory virusesFrancesca Barbieri, Maria Grazia Martina, Emanuela Pesce, et al.
European Journal of Medicinal Chemistry|July 17, 2021
System-oriented optimization of multi-target 2,6-diaminopurine derivatives: Easily accessible broad-spectrum antivirals active against flaviviruses, influenza virus and SARS-CoV-2Ilaria Vicenti, Maria Grazia Martina, Adele Boccuto, et al.
Journal of Medicinal Chemistry|December 4, 2014
Combining X-ray crystallography and molecular modeling toward the optimization of pyrazolo[3,4-d]pyrimidines as potent c-Src inhibitors active in vivo against neuroblastomaCristina Tintori, Anna Lucia Fallacara, Marco Radi, et al.
Journal of Medicinal Chemistry|March 21, 2012
2-(Alkyl/aryl)amino-6-benzylpyrimidin-4(3H)-ones as inhibitors of wild-type and mutant HIV-1: enantioselectivity studiesDante Rotili, Alberta Samuele, Domenico Tarantino, et al.
Journal of Medicinal Chemistry|August 24, 2013
New nucleotide-competitive non-nucleoside inhibitors of terminal deoxynucleotidyl transferase: discovery, characterization, and crystal structure in complex with the targetRoberta Costi, Giuliana Cuzzucoli Crucitti, Luca Pescatori, et al.
Chemmedchem|August 12, 2021
Bithiazole Inhibitors of Phosphatidylinositol 4-Kinase (PI4KIIIβ) as Broad-Spectrum Antivirals Blocking the Replication of SARS-CoV-2, Zika Virus, and Human RhinovirusesMaria Grazia Martina, Ilaria Vicenti, Lisa Bauer, et al.
Bioorganic Chemistry|August 6, 2022
Novel pyrazolo[3,4-d]pyrimidines as dual Src/Bcr-Abl kinase inhibitors: Synthesis and biological evaluation for chronic myeloid leukemia treatmentSalvatore Di Maria, Francesca Picarazzi, Mattia Mori, et al.
ACS Medicinal Chemistry Letters|May 22, 2020
Exploring the Implication of DDX3X in DENV Infection: Discovery of the First-in-Class DDX3X Fluorescent InhibitorAnnalaura Brai, Adele Boccuto, Martina Monti, et al.
Pageof 22

Showing results (181-190 of 214) with videos related to

Sort By:
Pageof 22
Journal of Medicinal Chemistry|March 3, 2006
Pyrazolo[3,4-d]pyrimidines as potent antiproliferative and proapoptotic agents toward A431 and 8701-BC cells in culture via inhibition of c-Src phosphorylationFabio Carraro, Antonella Naldini, Annalisa Pucci, et al.
Journal of Medicinal Chemistry|December 13, 2005
Parallel solution-phase and microwave-assisted synthesis of new S-DABO derivatives endowed with subnanomolar anti-HIV-1 activityFabrizio Manetti, José A Esté, Imma Clotet-Codina, et al.
European Journal of Medicinal Chemistry|September 10, 2025
Developing Type II F508del-CFTR correctors with a protective effect against respiratory virusesFrancesca Barbieri, Maria Grazia Martina, Emanuela Pesce, et al.
European Journal of Medicinal Chemistry|July 17, 2021
System-oriented optimization of multi-target 2,6-diaminopurine derivatives: Easily accessible broad-spectrum antivirals active against flaviviruses, influenza virus and SARS-CoV-2Ilaria Vicenti, Maria Grazia Martina, Adele Boccuto, et al.
Journal of Medicinal Chemistry|December 4, 2014
Combining X-ray crystallography and molecular modeling toward the optimization of pyrazolo[3,4-d]pyrimidines as potent c-Src inhibitors active in vivo against neuroblastomaCristina Tintori, Anna Lucia Fallacara, Marco Radi, et al.
Journal of Medicinal Chemistry|March 21, 2012
2-(Alkyl/aryl)amino-6-benzylpyrimidin-4(3H)-ones as inhibitors of wild-type and mutant HIV-1: enantioselectivity studiesDante Rotili, Alberta Samuele, Domenico Tarantino, et al.
Journal of Medicinal Chemistry|August 24, 2013
New nucleotide-competitive non-nucleoside inhibitors of terminal deoxynucleotidyl transferase: discovery, characterization, and crystal structure in complex with the targetRoberta Costi, Giuliana Cuzzucoli Crucitti, Luca Pescatori, et al.
Chemmedchem|August 12, 2021
Bithiazole Inhibitors of Phosphatidylinositol 4-Kinase (PI4KIIIβ) as Broad-Spectrum Antivirals Blocking the Replication of SARS-CoV-2, Zika Virus, and Human RhinovirusesMaria Grazia Martina, Ilaria Vicenti, Lisa Bauer, et al.
Bioorganic Chemistry|August 6, 2022
Novel pyrazolo[3,4-d]pyrimidines as dual Src/Bcr-Abl kinase inhibitors: Synthesis and biological evaluation for chronic myeloid leukemia treatmentSalvatore Di Maria, Francesca Picarazzi, Mattia Mori, et al.
ACS Medicinal Chemistry Letters|May 22, 2020
Exploring the Implication of DDX3X in DENV Infection: Discovery of the First-in-Class DDX3X Fluorescent InhibitorAnnalaura Brai, Adele Boccuto, Martina Monti, et al.
Pageof 22